JPRN-UMIN000003057已完成4 期
A study on efficacy and safety of a DPP-IV inhibitor in type 2 diabetes patients - Saga-challenge antiDiabetes Observantional study for sitaGliptin (S-DOG)
Saga lifestyle related disease treatment study group secretariat0 个研究点目标入组 300 人开始时间: 2010年1月19日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient with a history of severe ketosis, diabetic coma or pre-coma within the past 6 months 2) Patient with severe infection, a recent history of surgery, and those who are scheduled to undergo surgery soon, or serious external wound 3) Pregnant patients, including one trying to conceive pregnancy during the planned study period, and breast-feeding patients 4) Patients with modest to severe renal impairment (creatinine clearance >=30 mL/min; serum creatinine >=1.5mg/dL in men and >=1.3mg/dL in women) 5) Patients with a history of hypersensitivity to the study agent 6) Patients who are considered not eligible for the study by the attending doctor due to medical reasons
研究者
相似试验
已完成
不适用
A Study of Safety and Efficacy of DPP-4 inhibitor in the Treatment of type 2 diabetes in KanagawaType 2 diabetesJPRN-UMIN000014382Diabetes Committee, Kanagawa Physicians Association860
已完成
不适用
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000004678Keio University , School of Mecidicine, Department of Internal Medicine50
已完成
不适用
ong-term efficacy and safety of the DPP-4 inhibitors in Japanese patients with type 2 diabetes mellitus.Type 2 Diabetes mellitusJPRN-UMIN000038801akakinen clinic3,000
已完成
不适用
Examination of the usefulness of DPP-4 inhibitor in the treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000011862aka Kinen Clinic10
已完成
不适用
Clinical study examining effect of DPP-4 inhibitors on postprandial hyperlipidemiaType 2 diabetes mellitusJPRN-UMIN000010177Shimane University Faculty of Medicine30